HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 80 filers reported holding HARVARD BIOSCIENCE INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $237,026 | +7.7% | 85,569 | -0.2% | 0.00% | – |
| Q3 2022 | $220,000 | +50.7% | 85,723 | +110.7% | 0.00% | – |
| Q2 2022 | $146,000 | +94.7% | 40,689 | +37.8% | 0.00% | – |
| Q2 2017 | $75,000 | -61.9% | 29,528 | -61.1% | 0.00% | – |
| Q1 2017 | $197,000 | -16.2% | 75,845 | -1.7% | 0.00% | – |
| Q4 2016 | $235,000 | +13.5% | 77,183 | +1.6% | 0.00% | – |
| Q3 2016 | $207,000 | +4.0% | 75,954 | +9.4% | 0.00% | – |
| Q2 2016 | $199,000 | +2.6% | 69,443 | +7.9% | 0.00% | – |
| Q1 2016 | $194,000 | +1.0% | 64,383 | +16.2% | 0.00% | – |
| Q4 2015 | $192,000 | +269.2% | 55,409 | +300.8% | 0.00% | – |
| Q3 2015 | $52,000 | -52.7% | 13,824 | -28.1% | 0.00% | – |
| Q2 2015 | $110,000 | -42.7% | 19,218 | -41.8% | 0.00% | – |
| Q1 2015 | $192,000 | +231.0% | 33,046 | +223.9% | 0.00% | – |
| Q4 2014 | $58,000 | -13.4% | 10,204 | -27.6% | 0.00% | – |
| Q2 2013 | $67,000 | – | 14,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |